| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 12, 2017Virtual Press Office and PR Newswire: General Trade show news
The Institute of Internal Auditors (IIA) is pleased to announce the initial lineup of world-class speakers for its 2018 International Conference in Dubai, United Arab Emirates. With the theme...
-
Dec 11, 2017Virtual Press Office and PR Newswire: General Trade show news
Market Leaders Discuss How SEC Regulation A+ Provides Access to Promising Companies for Individual Investors NEW YORK, Dec. 11, 2017 /PRNewswire/ -- Cision® and CrowdfundX invite individual...
-
Dec 11, 2017Virtual Press Office and PR Newswire: General Trade show news
Founder and Chief Executive Officer of DotLab, Heather Bowerman, will be speaking at this year's Technology for Precision Health Summit (TPHS) Presented by Health 2.0. The conference will take...
-
Dec 11, 2017Virtual Press Office and PR Newswire: General Trade show news
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that preliminary safety and efficacy data from a phase 1 study of DS-3201, an investigational and potential...
-
Dec 11, 2017Virtual Press Office and PR Newswire: General Trade show news
RAPT Touch, the leader in alternative touchscreen technologies, will demonstrate its latest advancements in Interactive Flat Panel technology designed for the education market at BETT 2018. RAPT...
-
Dec 11, 2017Virtual Press Office and PR Newswire: General Trade show news
Amgen (NASDAQ: AMGN) today announced new results showing the positive overall survival (OS) findings from the final analysis of the Phase 3 ASPIRE trial. The study met the key secondary endpoint...
-
Dec 11, 2017Virtual Press Office and PR Newswire: General Trade show news
Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") announced today the first reported data of the investigational agent gilteritinib from the ongoing, open-label,...
-
Dec 11, 2017Virtual Press Office and PR Newswire: General Trade show news
Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151, President and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") announced today that the results of the Global Phase 3 study (MAVORIC: Mogamulizumab anti-CCR4...
-
Dec 11, 2017CES 2018 Exhibitor News releases, photos and supporting content
Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technologies and products for the consumer and enterprise markets,...
-
Dec 11, 2017Virtual Press Office and PR Newswire: General Trade show news
Lannett Company, Inc. (NYSE: LCI) today announced that the company will present at the BMO Capital Markets 2017 Prescription for Success Healthcare Conference on December 14, 2017 at 3:30 p.m....
